Michael Roche
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
Papers in
- Virology 45
- HIV Research and Treatment 45
-
- HIV/AIDS Research and Interventions 14
- HIV/AIDS drug development and treatment 14
- Co-authors
- Melissa J. Churchill (36 shared papers)Paul R. Gorry (32 shared papers)Lachlan Gray (15 shared papers)Anne Ellett (17 shared papers)Steve Wesselingh (10 shared papers)Sharon R. Lewin (27 shared papers)Jacqueline K. Flynn (11 shared papers)Jasminka Sterjovski (15 shared papers)
- Journals
- Retrovirology (7 papers)Journal of Virology (5 papers)Virology (4 papers)Viruses (4 papers)AIDS (3 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Michael Roche
50 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 86
- Virology 995
- Infectious Diseases 448
- Immunology 344
- Biological Psychiatry 35
- Emergency Medicine 90
Countries citing papers authored by Michael Roche
This map shows the geographic impact of Michael Roche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Roche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Roche more than expected).
Fields of papers citing papers by Michael Roche
This network shows the impact of papers produced by Michael Roche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Roche. The network helps show where Michael Roche may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Roche, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 98 | |
| 2 | 2007 | 73 | |
| 3 | 2011 | 67 | |
| 4 | 2007 | 60 | |
| 5 | 2020 | 59 | |
| 6 | 2014 | 56 | |
| 7 | 2013 | 54 | |
| 8 | 2010 | 52 | |
| 9 | 2009 | 50 | |
| 10 | 2022 | 49 | |
| 11 | 2013 | 47 | |
| 12 | 2021 | 40 | |
| 13 | 2019 | 37 | |
| 14 | 2011 | 35 | |
| 15 | 2012 | 33 | |
| 16 | 2015 | 33 | |
| 17 | 2011 | 28 | |
| 18 | 2010 | 27 | |
| 19 | 2018 | 26 | |
| 20 | 2021 | 25 |
About Michael Roche
Michael Roche is a scholar working on Virology, Infectious Diseases, Immunology, Molecular Biology and Epidemiology, having authored 52 papers that have together received 1.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (45 papers), HIV/AIDS Research and Interventions (14 papers), HIV/AIDS drug development and treatment (14 papers), Immune Cell Function and Interaction (11 papers), Cytomegalovirus and herpesvirus research (5 papers), RNA Interference and Gene Delivery (4 papers), T-cell and B-cell Immunology (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Virology (995 citations), Infectious Diseases (448 citations), Immunology (344 citations), Biological Psychiatry (35 citations) and Emergency Medicine (90 citations). Michael Roche has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Melissa J. Churchill, Paul R. Gorry, Lachlan Gray, Anne Ellett, Steve Wesselingh, Sharon R. Lewin, Jacqueline K. Flynn, Jasminka Sterjovski, Anthony L. Cunningham and Benhur Lee. Their work appears in journals such as Retrovirology, Journal of Virology, Virology, Viruses and AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.